Valuation: InterCure Ltd.

Market Cap 164M 0 143M 132M 122M 230M 15.75B 235M 1.58B 620M 7.71B 616M 602M 26.55B P/E 2024
-4.01x
P/E 2025 -4.87x
Enterprise Value 300M 0 262M 243M 224M 422M 28.84B 430M 2.89B 1.14B 14.12B 1.13B 1.1B 48.63B EV / Sales 2024
1.69x
EV / Sales 2025 1.16x
Free-Float
60.83%
Yield 2024 *
-
Yield 2025 -
1 day-0.13%
1 week-0.89%
Current month-8.93%
1 month+14.08%
3 months+30.12%
6 months-0.56%
Current year-7.35%
1 week 291
Extreme 291
310
1 month 264.7
Extreme 264.7
345
Current year 225.3
Extreme 225.3
359
1 year 225.3
Extreme 225.3
605
3 years 225.3
Extreme 225.3
1,346
5 years 225.3
Extreme 225.3
2,635
10 years 146.83
Extreme 146.8255
6,317.95
Manager TitleAgeSince
Chief Executive Officer 55 24/12/2019
Director of Finance/CFO 47 01/03/2020
General Counsel - 01/04/2022
Director TitleAgeSince
Director/Board Member 50 03/09/2015
Director/Board Member 66 14/12/2014
Chairman 55 13/02/2025
Date Insider Type Main position Quantity % Market Cap.
18/03Other

Director

26,149 0.0478%
18/03Other

Chief Executive Officer

17,285,455 31.6113%
18/03Other

Director

19,046 0.0348%
Change 5-day change 1-year change 3-year change Capi.($)
-0.13%-0.89%-41.20%-51.05% 54.3M
+0.99%+3.55%+54.55%+231.49% 231M
-1.57%-8.76%-38.12%-38.73% 126M
+6.15%+5.56%+6.74%+111.11% 125M
-0.38%+5.80%+1.74%+2.84% 95.86M
-8.00%+6.98%+17.95%-34.29% 101M
Average -0.49%+2.75%+0.28%+36.90% 122.34M
Weighted average by Cap. -0.08%+2.69%+11.40%+76.92%

Financials

2024 2025
Net sales 239M 0 209M 193M 178M 336M 22.94B 342M 2.3B 903M 11.23B 897M 877M 38.68B 270M 0 236M 218M 202M 380M 25.95B 387M 2.6B 1.02B 12.71B 1.01B 992M 43.76B
Net income -67.8M -0 -59.25M -54.77M -50.6M -95.29M -6.51B -97.01M -653M -256M -3.19B -255M -249M -10.98B -35.71M -0 -31.21M -28.85M -26.65M -50.19M -3.43B -51.1M -344M -135M -1.68B -134M -131M -5.78B
Net Debt 133M 0 116M 107M 99.08M 187M 12.75B 190M 1.28B 502M 6.24B 499M 488M 21.5B 136M 0 119M 110M 102M 192M 13.1B 195M 1.31B 515M 6.41B 512M 501M 22.08B
Logo InterCure Ltd.
InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
Employees
285
Date Price Change Volume
14/07/26 ILA 299.80 -0.13% 25,547
13/07/26 ILA 300.20 -2.85% 18,978
10/07/26 ILA 309.00 +4.18% 7,088
09/07/26 ILA 296.60 -2.69% 14,519
08/07/26 ILA 304.80 +0.76% 23,599
  1. Stock Market
  2. Stocks
  3. INCR Stock